Pay in 4 interest-free payments of $34.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
but not mTORC2
GSK-5959 (3a) also displays selectivity over the closely related family members
RA190 stabilized targets of human papillomavirus (HPV) E6 oncoprotein
33(2):300-9
IDH-C227 - IDH1 Inhibitor. CAS# 1355324-14-9 0232 but not mTORC2IDH C227, CAS No. 1355324 14 9, is a potent and selective IDH1 R132H inhibitor first reported in patent WO2012009678. It can inhibit the enzymatic activity of IDH1 R132H in vitro with an IC50 < 0. 1 M, and 2 HG production in HT1080 and U87MG cells with IC50 < 0. 25 M. Because the mutated form of IDH1 produces the metabolite, 2 hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas as well as other forms of
US$ 127.50
US$ 80.95
US$ 13.50